Pivotal bioVenture Partners Investment Advisor LLC

报告期 2026-03-31 · CIK 0001844645

持仓数

前50大市值合计

$279.8M

报告期

2026-03-31

当前持仓调仓

前 13 大持仓

标的

类型

市值

股数

占比*

PCVX VAXCYTE INC

COM

$79.8M

1,372,425

28.5%

— OCULIS HOLDING AG

ORDINARY SHARES

$44.7M

1,680,283

16.0%

EVMN EVOMMUNE INC

COM SHS

$44.3M

1,926,943

15.8%

ARQT ARCUTIS BIOTHERAPEUTICS INC

COM

$31.9M

1,355,892

11.4%

TRVI TREVI THERAPEUTICS INC

COM

$18.5M

1,553,726

6.6%

IMNM IMMUNOME INC

COM

$16.0M

732,512

5.7%

MPLT MAPLIGHT THERAPEUTICS INC

COM

$12.4M

611,447

4.4%

ZBIO ZENAS BIOPHARMA INC

COM

$11.6M

591,991

4.1%

BIOA BIOAGE LABS INC

COM

$11.4M

653,374

4.1%

AVTX AVALO THERAPEUTICS INC

COM NEW

$4.4M

295,933

1.6%

RLYB RALLYBIO CORP

COM

$2.7M

300,579

1.0%

RXRX RECURSION PHARMACEUTICALS IN

CL A

$1.8M

595,518

0.7%

BOLT BOLT BIOTHERAPEUTICS INC

COM NEW

$172.0K

42,581

0.1%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

84%前 6 大占比

PCVX28.5%OCULIS HOLDING AG16.0%EVMN15.8%ARQT11.4%TRVI6.6%IMNM5.7%